Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities
Status:
Not yet recruiting
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test perineural injections (injections around a nerve)
of incobotulinumtoxin-A in participants with diabetic nerve pain of the feet and lower legs.
The main questions it aims to answer are:
- Is the treatment safe and effective?
- Does the treatment affect participants quality of life, depression, physical activity,
daily life, and sensation?
Participants will be treated every 12 weeks, for a total of 24 weeks, with either
incobotulinumtoxin-A or a placebo.